Sensible Biotechnologies
Unlocking the next generation of mRNA medicines
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
The future of mRNA therapeutics is hampered by manufacturing challenges and unless solved, its exciting potential may never be realised. Sensible enables the next generation of mRNA medicines by turning living cells into factories producing abundant, highly stable and non-immunogenic mRNA in a scalable and cost-effective way. Sensible Biotechnologies is a Y Combinator company (Summer 2021). YC-listed status: Active.
- Website
- sensible.bio
- Location
- Oxford, England, United Kingdom
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- Sensible Biotechnologies — Cell-based mRNA design and manufacturing platform producing pure, low-immunogenicity mRNA for next-generation therapeutics. · Other
Links
- Y Combinator profileycombinator